Investor Briefing – TheraPharm GmbH Acquisition

Melbourne (Australia) – 1st December 2020. Telix Pharmaceuticals Provides Investor Briefing: TheraPharm GmbH Acquisition

Targeted Radiation for Cell Therapies – TheraPharm GmbH Acquisition.

To view the presentation please click here.

The Investor Call and Q&A was recorded and is now available for on-demand public viewing here.